Peripheral Neuropathic Pain
3 competing products in clinical development for Peripheral Neuropathic Pain.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| YHD1119 + Lyrica | Yuhan | Phase 3 | Completed | 40 |
| YHD1119 300mg + YHD1119 300mg | Yuhan | Phase 1 | Completed | 29 |
| Qutenza exposure | Astellas Pharma | Pre-clinical | Completed | 26 |